MSc Biopharmaceutical Development at University of Leeds

Programme overview

Designed, developed and delivered in partnership with Labcorp Drug Development, this Masters trains scientists for drug development in the biopharmaceutical industry, covering biologically manufactured drugs such as hormones, monoclonal antibodies, gene therapies and cell therapies.

Faculty: Faculty of Biological Sciences | Duration: 12 months full-time | Intake: September 2027 | Study mode: full-time | Location: Leeds, England, United Kingdom

What you will study

Compulsory modules include Introduction to Pharmaceutical Science and Commerce, Manufacturing Biopharmaceuticals, Integrated Drug Development Plan, Practical Skills for a Regulatory Environment, Biopharmaceutical Drug Discovery and Non-clinical Testing, Clinical Trials and a research project.

Career pathways

Graduates are prepared for roles such as research manager and quality control roles in the biopharmaceutical industry, or further research in academia.

Official programme page

Application information

Entry requirements

Bachelor degree with at least a 2:1 (hons) or equivalent in a biological sciences subject with a substantial molecular content, or in bioprocessing or biochemical engineering; relevant experience may be taken into account. International application deadline: 31 July 2027. IELTS 6.5 overall with no less than 6.0 in any component for international applicants.

Domestic applicants: GBP 16,500 for the whole programme (2027/28 entry). Total course fee (full-time) Source

International applicants: GBP 35,900 for the whole programme (2027/28 entry). Total course fee (full-time) Source

Intake: September 2027

Duration: 12 months full-time

Explore more study programmes

Health Sciences